Task: Answer the multiple-choice question.
Question: Which drug exhibits a -1.895\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
[a] CCOc1ccccc1NC(C)C(=O)NC(=O)NC1CCCCC1
[b] CCC(C)Nc1c2c(nc3c(-c4ccccc4)c(C)nn13)CCC2
Answer: b. CCC(C)Nc1c2c(nc3c(-c4ccccc4)c(C)nn13)CCC2
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC(C)Nc1c2c(nc3c(-c4ccccc4)c(C)nn13)CCC2
CCC(C)Nc1c2c(nc3c(-c4ccccc4)c(C)nn13)CCC2
N-butan-2-yl-11-methyl-10-phenyl-1,8,12-triazatricyclo[7.3.0.03,7]dodeca-2,7,9,11-tetraen-2-amine